4D Molecular Therapeutics

FDMT · NASDAQ

$13.10+$0.81 (+6.59%)TodayMarket closed ·
Prev close $12.29

Who owns FDMT

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 65.8% of FDMT’s shares.

  • Janus Henderson Investors11.0%
  • RA Capital Management, LP9.7%
  • Goldman Sachs & Co. LLC7.3%
  • BlackRock Institutional Trust Company, N.A.7.1%
  • Next 6 largest institutions30.7%
  • All other shareholders34.2%
Top institutional holders of FDMT
HolderShares% of shares
Janus Henderson Investors5.75M10.99%
RA Capital Management, LP5.05M9.66%
Goldman Sachs & Co. LLC3.84M7.34%
BlackRock Institutional Trust Company, N.A.3.74M7.15%
Novo Holdings A/S3.25M6.21%
State Street Investment Management (US)2.91M5.57%
BVF Partners L.P.2.88M5.51%
T. Rowe Price Investment Management, Inc.2.51M4.80%
Adage Capital Management, L.P.2.25M4.30%
Trails Edge Capital Partners LP2.23M4.26%

Largest mutual fund holders

Top mutual fund holders of FDMT
HolderShares% of shares
State Street SPDR S&P Biotech ETF1.70M3.25%
Vanguard Total Stock Market Index Fund1.59M3.04%
iShares Russell 2000 ETF1.19M2.28%
Janus Henderson Horizon Biotechnology904.51K1.73%
Janus Henderson Global Life Sciences Fund793.17K1.52%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $5.29M (18 trades) of FDMT on the open market, with no buys.

Latest FDMT insider transactions
InsiderTypeSharesValue
Kirn DavidSale272$3.70K
Kirn DavidSale58.06K$750.24K
Bizily ScottOption exercise1.64K—
Bizily ScottSale1.64K$22.32K
Bizily ScottOption exercise1.64K$6.77K
Kirn DavidSale58.33K$811.00K
Bizily ScottOption exercise584—
Bizily ScottSale584$8.18K
Bizily ScottOption exercise584$3.79K
Kirn DavidOption exercise50.00K—

Short interest

Settled Sep 30, 2026

Shares short
11.24M
Days to cover
9.33
% of shares outstanding
21.50%
Average daily volume
1.20M
Change since last report
−6.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.